Literature DB >> 17261337

Evaluation of diastolic function by the Tissue doppler in children affected by non-compaction.

Giovanni Fazio, Salvatore Pipitone, Maria Aurora Iacona, Salvatore Marchì, Maurizio Mongiovì, Rosanna Zito, Loredana Sutera, Giuseppina Novo, Salvatore Novo.   

Abstract

The Tissue doppler analysis is a new echocardiographic approach to evaluate the diastolic function. In this report we performed a Tissue doppler analysis in a series of 15 children affected by non-compaction. The bidimensional echo-cardiogram showed a systolic function which was reduced only in 8 patients. Alterations of the diastolic function were founded in 7 patients: in 2 cases, a reduction of the E tissue wave was present in all segments. In 3 patients the diastolic dysfunction was limited to apical and lateral segments. In the last 2 children a reduction of the E wave interested only the apical segments. There was a strong correlation between systolic and diastolic dysfunction: in fact all patients with diastolic dysfunction also presented a severe reduction of the systolic function.

Entities:  

Mesh:

Year:  2007        PMID: 17261337     DOI: 10.1016/j.ijcard.2006.07.205

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Systolic-diastolic coupling of myocardial deformation of the left ventricle in children with left ventricular noncompaction.

Authors:  C Koh; W J Hong; S J Wong; Y F Cheung
Journal:  Heart Vessels       Date:  2010-09-28       Impact factor: 2.037

2.  Noncompaction of the right ventricle.

Authors:  Giovanni Fazio; Monica Lunetta; Emanuele Grassedonio; Alessandro Gullotti; Giovani Ferro; Daniela Bacarella; Giuseppe Lo Re; Giuseppina Novo; Midiri Massimo; Emiliano Maresi; Salvatore Novo
Journal:  Pediatr Cardiol       Date:  2010-05       Impact factor: 1.655

3.  Assessment of left ventricular diastolic function in children after successful repair of aortic coarctation.

Authors:  Tomasz Florianczyk; Bozena Werner
Journal:  Clin Res Cardiol       Date:  2010-12-31       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.